Patients With Acute Hip Fractures Will Receive Either the PENG Block or no Block Respectively.
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Hip fracture pain is often severe and traditionally managed by systemic opioids which have
increased risk of side effects in frail elderly patients. Inadequately controlled pain may
lead to delirium which increases mortality and morbidity. The overall aim of this RCT is to
investigate the potential for improved pain relief accomplished by the addition of the PENG
block to current standard practice of pre-operative analgesia (systemic morphine), compared
to the control group, which involves no block (operator will still go through the motion as
if performing a block) plus standard pre-operative analgesia.
The investigator hypothesize that the addition of a single shot PENG block at the side of hip
fracture in addition to traditional systemic morphine provides good preoperative pain relief
on movement and reduces the need for breakthrough opioid requirements. The investigator
hypothesize that the interventional group dynamic pain score assessed at 30 minutes after the
block compared to control group dynamic pain score at 30 minutes after the "block" will be at
least a 3 point difference between the 2 groups .